Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Jul 31, 2025 | (Q2)Apr 30, 2025 | (Q1)Jan 31, 2025 | (FY)Oct 31, 2024 | (Q4)Oct 31, 2024 | (Q3)Jul 31, 2024 | (Q2)Apr 30, 2024 | (Q1)Jan 31, 2024 | (FY)Oct 31, 2023 | (Q4)Oct 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 62.96%-11.78K | 1.20%-82.35K | -152.53%-111.08K | -23.16%-289.46K | -24.36%-130.34K | 53.56%-31.79K | -126.02%-83.35K | -76.79%-43.99K | 68.80%-235.02K | -9.44%-104.8K |
| Net income from continuing operations | 35.06%-6.1K | -47.79%-37.36K | -311.76%-88.52K | 20.97%-287.55K | -55.80%-231.39K | 80.37%-9.39K | 81.40%-25.28K | 32.04%-21.5K | 70.61%-363.85K | 51.90%-148.51K |
| Operating gains losses | -75.00%-19.25K | 69.23%-5.5K | ---- | ---- | ---- | 45.95%-11K | -137.36%-17.88K | ---- | ---- | ---- |
| Unrealized gains and losses of investment securities | ---- | ---- | 2,500.00%35.75K | -148.00%-33K | ---- | ---- | ---- | --1.38K | -79.17%68.75K | ---- |
| Remuneration paid in stock | ---- | --0 | --0 | --64.92K | ---- | ---- | --0 | --0 | --0 | ---- |
| Other non cashItems | 140.00%4 | 2.40%128 | -0.98%-103 | -61.95%-21K | -61.85%-21.01K | 0.00%-10 | -0.79%125 | 0.00%-102 | -224.18%-12.97K | -220.36%-12.98K |
| Change In working capital | 219.07%13.57K | 1.75%-39.62K | -144.97%-58.21K | -117.57%-12.83K | 305.64%62.64K | -3,911.97%-11.39K | -179.01%-40.32K | -446.64%-23.76K | 451.92%73.05K | 53.54%15.44K |
| -Change in receivables | -110.69%-1.68K | -41.19%5.17K | -530.56%-4.02K | -80.80%3.46K | -46.17%-3.9K | 81.75%-795 | -66.42%8.79K | 43.59%-638 | 513.54%18.02K | -19.44%-2.67K |
| -Change in prepaid assets | --15.14K | --0 | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| -Change in payables and accrued expense | 100.94%100 | 8.81%-44.78K | -134.33%-54.19K | -129.61%-16.29K | 267.44%66.54K | -360.35%-10.6K | -297.55%-49.11K | -389.56%-23.12K | 348.52%55.03K | 28.51%18.11K |
| -Change in other current liabilities | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 62.96%-11.78K | 1.20%-82.35K | -152.53%-111.08K | -23.16%-289.46K | -24.36%-130.33K | 53.56%-31.79K | -126.02%-83.35K | -76.79%-43.99K | 68.80%-235.02K | -9.44%-104.8K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -28.97%-116.15K | 0 | 0 | -9.20%-248.85K | -256.71%-124.85K | -50.40%-90.06K | 0 | -33.94K | -70.95%-227.87K | 54.10%-35K |
| Net PPE purchase and sale | -28.97%-116.15K | --0 | --0 | -9.20%-248.85K | -256.71%-124.85K | -50.40%-90.06K | --0 | ---33.94K | ---227.87K | ---35K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -28.97%-116.15K | --0 | --0 | -9.20%-248.85K | -256.71%-124.85K | -50.40%-90.06K | --0 | ---33.94K | -70.95%-227.87K | 54.10%-35K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 5.00%105K | -5.88%80K | 47.06%125K | 36.74%532.2K | 183.45%262.2K | 38.41%100K | -62.13%85K | 85K | -29.63%389.19K | -46.94%92.5K |
| Net issuance payments of debt | 5.00%105K | -5.88%80K | 47.06%125K | --395K | --125K | --100K | --85K | --85K | --0 | --0 |
| Net common stock issuance | --0 | --0 | --0 | -30.10%148.75K | 270.00%148.75K | --0 | --0 | --0 | 9.13%212.8K | 57.88%-87.5K |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -13.36%180K | ---- |
| Net other financing activities | ---- | ---- | ---- | -220.18%-11.55K | ---- | ---- | ---- | ---- | 85.41%-3.61K | 100.15%1 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 5.00%105K | -5.88%80K | 47.06%125K | 36.74%532.2K | 183.45%262.2K | 38.41%100K | -62.13%85K | --85K | -29.63%389.19K | -46.94%92.5K |
| Net cash flow | ||||||||||
| Beginning cash position | -5.43%28.13K | 2.47%30.48K | -26.95%16.56K | -76.48%22.66K | -86.36%9.54K | -76.40%29.74K | -58.39%29.74K | -76.48%22.66K | -77.58%96.36K | -25.61%69.96K |
| Current changes in cash | -13.50%-22.93K | -242.28%-2.35K | 96.65%13.92K | 91.71%-6.11K | 114.83%7.02K | 63.98%-20.2K | -96.97%1.65K | 128.45%7.08K | 77.90%-73.7K | -2,144.12%-47.3K |
| End cash Position | -45.50%5.2K | -10.40%28.13K | 2.47%30.48K | -26.95%16.56K | -26.95%16.56K | -86.36%9.54K | -75.10%31.39K | -58.39%29.74K | -76.48%22.66K | -76.48%22.66K |
| Free cash from | -4.99%-127.93K | 1.20%-82.35K | -42.55%-111.08K | -16.29%-538.31K | -82.53%-255.18K | 5.05%-121.85K | 50.93%-83.35K | -213.19%-77.92K | 38.54%-462.89K | -261.11%-139.8K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.